Cargando…

Evaluation of the Effect of Carvedilol in Preventing Right Ventricular Dysfunction in Breast Cancer Patients Receiving Anthracycline

BACKGROUND: Today, it has been shown that it is possible for right ventricular (RV) wall motion abnormalities or RV functional disorders to occur during cancer treatment. Now, considering the effect of carvedilol on beta 1, 2, and alpha receptors and its antioxidant properties, it seems that it can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karvandi, Mersede, Ghadyani, Mojtaba, Mohebbi, Nahid, Tabarraee, Mehdi, Salari, Sina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012032/ https://www.ncbi.nlm.nih.gov/pubmed/36926423 http://dx.doi.org/10.4103/abr.abr_134_21

Ejemplares similares

Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Thenappan, Thenappan, et al.
Publicado: (2021)

Bone marrow transplantation may augment cardiac systolic function in patients with a reduced left ventricular ejection fraction
por: Piranfar, Mohammad A., et al.
Publicado: (2012)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin
por: Abuosa, Ahmed Mohamed, et al.
Publicado: (2018)

The Lack of Synergy between Carvedilol and the Preventive Effect of Dexrazoxane in the Model of Chronic Anthracycline-Induced Cardiomyopathy
por: Szponar, Jaroslaw, et al.
Publicado: (2023)

Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
por: El-Sherbeny, Wafaa S., et al.
Publicado: (2023)

Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia
por: Tual, L, et al.
Publicado: (2006)

Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia
por: Silvilairat, Suchaya, et al.
Publicado: (2021)

Comparison of Mirtazapine and Olanzapine on Nausea and Vomiting following Anthracycline-cyclophosphamide Chemotherapy Regimen in Patients with Breast Cancer
por: Maleki, Alimohammad, et al.
Publicado: (2020)

Carvedilol Prevents Ovariectomy-Induced Myocardial Contractile Dysfunction in Female Rat
por: Ribeiro, Rogerio Faustino, et al.
Publicado: (2013)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
por: Kwon, Hye Won, et al.
Publicado: (2012)

Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
por: de Souza, Thiago Ferreira, et al.
Publicado: (2021)

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction
por: Ozaydin, Mehmet, et al.
Publicado: (2016)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients
por: Wibawa Martha, Januar, et al.
Publicado: (2020)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
por: Zhao, Rui, et al.
Publicado: (2020)

Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis
por: Wu, Ping-Hsun, et al.
Publicado: (2021)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Anthracycline dose and liver dysfunction
por: Cannizzaro, R, et al.
Publicado: (1999)

Subclinical Ventricular Dysfunction Detected by Speckle Tracking Two Years after Use of Anthracycline
por: de Almeida, André Luiz Cerqueira, et al.
Publicado: (2015)

Subclinical Ventricular Dysfunction Detected by Speckle-Tracking Two Years after Use of Anthracycline
por: Freitas Jr., Aguinaldo Figueiredo, et al.
Publicado: (2015)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
por: Frishman, William H, et al.
Publicado: (2008)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Biomarkers and Right Ventricular Dysfunction
por: Pradhan, Natasha M., et al.
Publicado: (2020)

Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
por: Lenčová-Popelová, Olga, et al.
Publicado: (2014)

Serum Prealbumin: a potential predictor of Right Ventricular Dysfunction in patients receiving programmed hemodialysis
por: Gok, Murat, et al.
Publicado: (2022)

Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
por: Wanderley Jr., Mauro Rogério de Barros, et al.
Publicado: (2022)

Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival
por: Dominguez, Renata F, et al.
Publicado: (2019)

Diastolic And Systolic Right Ventricular Dysfunction Precedes Left Ventricular Dysfunction In Patients Paced From Right Ventricular Apex
por: Dwivedi, SK, et al.
Publicado: (2006)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Right ventricular dysfunction in patients with acute respiratory distress syndrome receiving venovenous extracorporeal membrane oxygenation
por: Brown, Tyler N., et al.
Publicado: (2023)

Comment on “Serum prealbumin: a potential predictor of right ventricular dysfunction in patients receiving programmed hemodialysis”
por: Fang, Longcai, et al.
Publicado: (2023)

Right ventricular dysfunction in COVID-19
por: Bhattacharyya, Amrita, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Isolated, premature ventricular complex–induced right ventricular dysfunction mimicking arrhythmogenic right ventricular cardiomyopathy
por: Berruezo, Antonio, et al.
Publicado: (2018)

The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
por: Hilaj, Erina, et al.
Publicado: (2020)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ea2468alrbfvj01bhevamcqo63